Phenopen Review CBD
Canadian marijuana company Tilray on Tuesday reported revenue of 60.9 million Canadian dollars ($45.9 million) for the second quarter, up almost four times from the same period in 2018.
Net loss for the period, which ended June 30, was $35.05 million compared with a $12.83 million loss in the second quarter 2018.
Tilray, based in British Columbia, trades as TLRY on the Nasdaq.
The company’s share price was up over 8% in trading after the results were released.
More details can be found here.